PASSAGE BIO INC. - COMMON STOCK
0.6294
01-November-24 14:58:16
15 minutes delayed
Stocks
+0.0144
+2.34%
Today's range
0.6100 - 0.6500
ISIN
N/A
Source
NASDAQ
-
Passage Bio Announces Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
17 Sep 2021 15:01:00 By Nasdaq GlobeNewswire
-
Passage Bio Announces Maxine Gowen, Ph.D., as Chairwoman of the Board of Directors
07 Sep 2021 06:00:02 By Nasdaq GlobeNewswire
-
Passage Bio to Present at Citi 16th Annual BioPharma Virtual Conference
02 Sep 2021 06:00:01 By Nasdaq GlobeNewswire
-
Passage Bio Announces Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
27 Aug 2021 15:01:00 By Nasdaq GlobeNewswire
-
Passage Bio Mourns the Sudden Passing of Chairman of the Board Tadataka Yamada, M.D.
04 Aug 2021 20:00:00 By Nasdaq GlobeNewswire
-
Passage Bio to Present at 12th Annual Wedbush PacGrow Healthcare Conference
04 Aug 2021 06:00:01 By Nasdaq GlobeNewswire
-
Passage Bio to Report Second Quarter 2021 Financial Results on August 5, 2021
29 Jul 2021 06:00:01 By Nasdaq GlobeNewswire
-
21 Jul 2021 06:00:01 By Nasdaq GlobeNewswire
-
Passage Bio Announces Key Executive Appointments
19 Jul 2021 06:00:01 By Nasdaq GlobeNewswire
-
Derrell D. Porter, M.D., Elected to Board of Directors of Passage Bio
01 Jun 2021 06:00:00 By Nasdaq GlobeNewswire
-
Passage Bio to Participate in Upcoming June Investor Conferences
26 May 2021 06:00:01 By Nasdaq GlobeNewswire
-
Passage Bio Announces Pre-Clinical Data Presentation at Annual ASGCT Meeting
11 May 2021 05:30:00 By Nasdaq GlobeNewswire
-
Passage Bio to Host Virtual R&D Event on May 17
10 May 2021 06:00:00 By Nasdaq GlobeNewswire
-
Passage Bio Reports First Quarter 2021 Financial Results and Recent Business Highlights
05 May 2021 06:00:02 By Nasdaq GlobeNewswire
-
03 May 2021 06:00:01 By Nasdaq GlobeNewswire
-
Passage Bio to Report First Quarter 2021 Financial Results on May 5, 2021
29 Apr 2021 06:00:01 By Nasdaq GlobeNewswire
-
05 Apr 2021 06:00:00 By Nasdaq GlobeNewswire
-
01 Apr 2021 06:00:00 By Nasdaq GlobeNewswire
-
Passage Bio to Participate in Upcoming April Investor Conferences
25 Mar 2021 06:00:00 By Nasdaq GlobeNewswire
-
Passage Bio Appoints Eliseo O. Salinas, M.D., MSc, as Chief Research & Development Officer
22 Mar 2021 06:00:00 By Nasdaq GlobeNewswire